ANKRD44-AS1

Across TCGA pan-cancer cohorts, ANKRD44-AS1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of ANKRD44-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where ANKRD44-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types ANKRD44-AS1 is over-expressed in tumor, although a few such as KICH and COAD show the opposite, repressed pattern.

KICH, COAD, and LUSC are the cancer types where ANKRD44-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANKRD44-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	III,IV	−0.894	<.001	10	view →
COAD	All	II,III,IV	−0.411	<.001	9	view →
LUSC	Male	III,IV	−3.880	<.001	8	view →
LUAD	All	III,IV	−2.157	<.001	8	view →
THCA	All	II,III,IV	−0.298	.008	5	view →
BLCA	All	All	−1.229	.003	4	view →
CHOL	All	All	+0.425	<.001	3	view →
BRCA	All	IV	−0.520	.017	2	view →
STAD	Female	III,IV	+1.230	.043	1	view →
READ	All	All	−0.566	.019	1	view →
HNSC	Male	II,III,IV	−0.305	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

ANKRD44-AS1–KICH

Open the KICH breakdown →